Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF), a leader in genomics-based tests in health, wellness and serious disease, has signed a landmark distribution agreement with Stayhealthy, Inc., a leader in health and wellness technology, for Stayhealthy's innovative Multi-Risk Test.
This partnership will see the Multi-Risk Test of Stayhealthy distributed to a broader audience in the online pharmacy channel by Genetic Technologies’ GeneType brand across North America, empowering individuals to take control of their health.
GeneType will distribute the Multi-Risk Test via StayHealthyRx, enhancing the reach of its portfolio of personalized health risk assessments across North America.
Help with decisions
This collaboration will provide users with comprehensive insights into their health risks and actionable steps to mitigate them.
Genetic Technologies CEO Simon Morriss said: "We are excited to partner with Stayhealthy and bring the innovative Multi-Risk Test to their customers.
“This test will help individuals make informed health decisions and improve their quality of life."
GTG shares are up 15% in ASX trading this afternoon to A$0.115.
About Stayhealthy
Stayhealthy, Inc. is at the forefront of integrating technology with health solutions. The company's mission is to empower, inspire and give hope to individuals, families and communities through enhanced technology and a global wellness network.
The company’s FDA-cleared technologies have enabled users to measure, track and improve their health significantly.
In 2023, Stayhealthy launched an online discount pharmacy with 1.5 million users and a Level 5 cafeteria workers insurance plan covering more than 100,000 employees.
With a database exceeding 200 million US email addresses, Stayhealthy is well-positioned to promote this new offering.
John Collins, who was previously successful in the music industry and public relations, was inspired to transform healthcare after a personal experience.
Health management tool
His extensive industry connections have been instrumental in Stayhealthy's growth and he serves as the company’s CEO.
"Partnering with GeneType allows us to reach more people with Gene Types Multi-Risk Test, offering a powerful tool for health management," said Collins.
"Genetype's expertise in non-invasive genetic testing complements our technology perfectly," he added.